Is DaVita Stock Outperforming the Dow?

DaVita Inc. (DVA) is a leading provider of dialysis services in the U.S., specializing in care for patients with chronic kidney failure, also known as end-stage renal disease (ESRD). With a market cap of $14.2 billion, the company operates numerous dialysis centers and offers a variety of related medical services.

Companies valued at $10 billion or more are generally considered "large-cap" stocks, and DaVita fits this criterion perfectly. DaVita is renowned for its extensive network of outpatient and inpatient dialysis centers and its strong focus on integrated care and disease management services, making it a leader in the U.S. dialysis market with a significant patient base.